Long-Term Survival of Patient with Epstein-Barr Virus-Positive Gastric Cancer Treated with Chemotherapy: Case Report

Overview

Journal J Gastrointest Cancer

Publisher Springer

Specialties Gastroenterology
Oncology

Date 2015 May 15

PMID 25972063

Citations 4

Authors

Hideo Yanai

Noboru Yahara

Takumi Furuya

Hiroto Hayashi

Tomoyuki Murakami

Yuzo Shimokawa

Shigenori Sugihara

Affiliations

Soon will be listed here.

Citing Articles

Endoscopic Diagnosis and Therapy for Epstein-Barr Virus-Associated Gastric Cancer.

Yanai H, Fujiwara J, Toyama E, Okuda H, Miura O, Kaino S Microorganisms. 2023; 11(11).

PMID: 38004633 PMC: 10673609. DOI: 10.3390/microorganisms11112619.

Epstein-Barr virus detection in endoscopic submucosal dissection-proven early gastric cancer with mixed-type histology.

Yanai H, Chihara D, Harano M, Sakaguchi E, Kaino S, Murakami T Cancer Rep (Hoboken). 2022; 6(5):e1730.

PMID: 36421012 PMC: 10172166. DOI: 10.1002/cnr2.1730.

Endoscopic and pathologic motifs for the clinical diagnosis of Epstein-Barr virus-associated gastric cancer.

Yanai H, Chihara D, Harano M, Sakaguchi E, Murakami T, Nishikawa J DEN Open. 2022; 1(1):e7.

PMID: 35310151 PMC: 8828195. DOI: 10.1002/deo2.7.

Epstein-Barr Virus-associated Early Gastric Cancer Treated with Endoscopic Submucosal Dissection: A Possible Candidate for Extended Criteria of Endoscopic Submucosal Dissection.

Yanai H, Chihara D, Harano M, Sakaguchi E, Murakami T, Nishikawa J Intern Med. 2019; 58(22):3247-3250.

PMID: 31735737 PMC: 6911759. DOI: 10.2169/internalmedicine.3055-19.

References

Hartgrink H, Jansen E, van Grieken N, van de Velde C . Gastric cancer. Lancet. 2009; 374(9688):477-90. PMC: 4613761. DOI: 10.1016/S0140-6736(09)60617-6. View

Camargo M, Kim W, Chiaravalli A, Kim K, Corvalan A, Matsuo K . Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2013; 63(2):236-43. PMC: 4384434. DOI: 10.1136/gutjnl-2013-304531. View

Feng W, Israel B, Raab-Traub N, Busson P, Kenney S . Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. Cancer Res. 2002; 62(6):1920-6. View

Burke A, Yen T, Shekitka K, Sobin L . Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990; 3(3):377-80. View

Watanabe H, Enjoji M, Imai T . Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976; 38(1):232-43. DOI: 10.1002/1097-0142(197607)38:1<232::aid-cncr2820380135>3.0.co;2-4. View

Murphy G, Pfeiffer R, Camargo M, Rabkin C . Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009; 137(3):824-33. PMC: 3513767. DOI: 10.1053/j.gastro.2009.05.001. View

Yanai H, Nishikawa J, Mizugaki Y, Shimizu N, Takada K, Matsusaki K . Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma. Gastrointest Endosc. 1997; 45(3):236-42. DOI: 10.1016/s0016-5107(97)70265-7. View

Matsunou H, Konishi F, Hori H, Ikeda T, Sasaki K, Hirose Y . Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer. 1996; 77(10):1998-2004. DOI: 10.1002/(SICI)1097-0142(19960515)77:10<1998::AID-CNCR6>3.0.CO;2-D. View

Seo J, Kim T, Hong Y, Chen J, Lee S . Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil. Arch Pharm Res. 2011; 34(4):635-43. DOI: 10.1007/s12272-011-0414-7. View

10.

Song H, Srivastava A, Lee J, Kim Y, Kim K, Kang W . Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology. 2010; 139(1):84-92.e2. DOI: 10.1053/j.gastro.2010.04.002. View

11.

Nishikawa J, Yanai H, Hirano A, Okamoto T, Nakamura H, Matsusaki K . High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction. Scand J Gastroenterol. 2002; 37(7):825-9. View

12.

Yanai H, Murakami T, Yoshiyama H, Takeuchi H, Nishikawa J, Nakamura H . Epstein-Barr virus-associated gastric carcinoma and atrophic gastritis. J Clin Gastroenterol. 1999; 29(1):39-43. DOI: 10.1097/00004836-199907000-00010. View

13.

Seya T, Tanaka N, Yokoi K, Ishikawa N, Horiba K, Kanazawa Y . Complete response of a patient with advanced gastric cancer, showing Epstein-Barr virus infection, to preoperative chemotherapy with S-1 and cisplatin. Int J Clin Oncol. 2007; 12(6):472-7. DOI: 10.1007/s10147-007-0682-x. View

14.

Shin H, Kim D, Lee S . Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma. Mol Cells. 2011; 32(2):173-9. PMC: 3887666. DOI: 10.1007/s10059-011-0066-y. View

15.

Wang Q, Tsao S, Ooka T, Nicholls J, Cheung H, Fu S . Anti-apoptotic role of BARF1 in gastric cancer cells. Cancer Lett. 2005; 238(1):90-103. DOI: 10.1016/j.canlet.2005.06.023. View

16.

Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N . Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A. 1994; 91(19):9131-5. PMC: 44761. DOI: 10.1073/pnas.91.19.9131. View

17.

Tokunaga M, Uemura Y, Tokudome T, ISHIDATE T, Masuda H, Okazaki E . Epstein-Barr virus related gastric cancer in Japan: a molecular patho-epidemiological study. Acta Pathol Jpn. 1993; 43(10):574-81. DOI: 10.1111/j.1440-1827.1993.tb03233.x. View